On Feb. 17, 2021, Moderna announced that the European Commission had purchased an additional 150 million doses of the COVID-19 Vaccine Moderna, which were scheduled to be delivered in the third and fourth quarter of 2021. This brought its confirmed order commitment to 310 million doses for delivery in 2021.

Under the terms of the agreement, the European Commission had the option to purchase an additional 150 million doses to be delivered in 2022.